Early effects of empagliflozin on exercise tolerance in patients with heart failure: A pilot study.

Julio NunezPatricia PalauEloy DomínguezAnna MollarEduardo NúñezJose María RamónGema MinanaEnrique SantasLorenzo FácilaJose Luis GórrizJuan SanchisAntoni Bayés-Genís

Published in: Clinical cardiology (2018)

In this pilot study, empagliflozin was associated with 1-month improvement in exercise capacity in T2DM patients with symptomatic HF. This beneficial effect was also found for other surrogates of severity.

Keyphrases

high intensity
physical activity
resistance training
type diabetes
skeletal muscle
acute heart failure
insulin resistance